rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2010-10-19
|
pubmed:abstractText |
Vascular Endothelial Growth Factor (VEGF) plays a prominent role in tumor angiogenesis and plasma VEGF concentration may carry prognostic information in colorectal cancer. The VEGF receptor 1 (VEGFR-1) is a regulatory receptor which is shredded into plasma of patients with colorectal cancer. For both molecules, large biological variation and lack of standardization of assay procedures are major challenges.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1502-7686
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
70
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
503-11
|
pubmed:meshHeading |
pubmed-meshheading:20873967-Adult,
pubmed-meshheading:20873967-Aged,
pubmed-meshheading:20873967-Aged, 80 and over,
pubmed-meshheading:20873967-Case-Control Studies,
pubmed-meshheading:20873967-Colorectal Neoplasms,
pubmed-meshheading:20873967-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:20873967-Female,
pubmed-meshheading:20873967-Humans,
pubmed-meshheading:20873967-Male,
pubmed-meshheading:20873967-Middle Aged,
pubmed-meshheading:20873967-Tumor Markers, Biological,
pubmed-meshheading:20873967-Vascular Endothelial Growth Factor A,
pubmed-meshheading:20873967-Vascular Endothelial Growth Factor Receptor-1
|
pubmed:year |
2010
|
pubmed:articleTitle |
Biological variations in plasma VEGF and VEGFR-1 may compromise their biomarker value in colorectal cancer.
|
pubmed:affiliation |
Department of Surgical Gastroenterology, Hvidovre Hospital, University of Copenhagen, Hvidovre, Denmark. madsnsvendsen@hotmail.com
|
pubmed:publicationType |
Journal Article
|